Trial Profile
Influence of Olmesartan and azelnidipine on renal function during cardiac surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension; Renal impairment
- Focus Therapeutic Use
- 31 Oct 2014 New trial record